Elevated rates just made it harder to build more homes in America

Multifamily lending on pace to surpass 2025’s robust volume – Scotsman Guide Skip to content error: Content is protected !! This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We may also share information about your use of our site with our social media, advertising…

The S&P 500 Index ($SPX) (SPY) is down by -0.03% today, the Dow Jones Industrial Average ($DOWI) (DIA) is down by -0.23%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.20%.  December E-mini S&P futures (ESZ26) are down -0.05%, and December E-mini Nasdaq futures (NQZ26) are up +0.17%. Stock indexes are mixed today, with the Nasdaq 100 posting…

The case kept moving. U.S. Bank Trust, which succeeded FNMA as the foreclosing party, secured a default judgment against all nonappearing defendants in June 2022. The matter was referred to a referee to calculate the amount owed.  The borrower surfaced in March 2023 – nearly four years later – and moved to dismiss the complaint…

Canada Prime Minister Mark Carney on Saturday announced his country would impose “dollar-for-dollar” tariffs on U.S. goods — a retaliatory measure after trade talks between the two nations broke down.

When you think of a Tennessee mountain estate, a winery might not come to mind. But, maybe it should—particularly for those buyers seeking a slice of vineyard life for a fraction of the price they would find in California. Perched on a beautiful 33.5-acre estate, with rolling fields, mature vineyards, and endless views, Villa Nove…

CRISPR Therapeutics (CRSP -4.41%), a gene editing-focused biotech, has made significant clinical and regulatory progress over the past five years. However, over this period, the company has lagged broader equities. CRISPR Therapeutics’ shares have declined by about 47% since mid-October 2021, while the S&P 500 has gained almost 73%, as of writing. Will CRISPR Therapeutics…